BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19110031)

  • 41. Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein.
    Schneider AM; Griffiths IR; Readhead C; Nave KA
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4447-51. PubMed ID: 7538670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative immunocytochemistry of Pelizaeus-Merzbacher disease, the jimpy mouse, and the myelin-deficient rat.
    Koeppen AH; Barron KD; Csiza CK; Greenfield EA
    J Neurol Sci; 1988 Apr; 84(2-3):315-27. PubMed ID: 2454299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease.
    Gow A; Southwood CM; Lazzarini RA
    J Cell Biol; 1998 Feb; 140(4):925-34. PubMed ID: 9472043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
    J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Jimpy(msd) mouse mutation and connatal Pelizaeus-Merzbacher disease.
    Yamamoto T; Nanba E; Zhang H; Sasaki M; Komaki H; Takeshita K
    Am J Med Genet; 1998 Feb; 75(4):439-40. PubMed ID: 9482656
    [No Abstract]   [Full Text] [Related]  

  • 46. Expression of the jimpy gene in the spinal cords of heterozygous female mice. I. An early myelin deficit followed by compensation.
    Bartlett WP; Skoff RP
    J Neurosci; 1986 Oct; 6(10):2802-12. PubMed ID: 3760935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Jimpy mutation affects astrocytes: lengthening of the cell cycle in vitro.
    Knapp PE; Skoff RP
    Dev Neurosci; 1993; 15(1):31-6. PubMed ID: 8269866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical neurophysiology in GJA12-related hypomyelination vs Pelizaeus-Merzbacher disease.
    Henneke M; Gegner S; Hahn A; Plecko-Startinig B; Weschke B; Gärtner J; Brockmann K
    Neurology; 2010 Jun; 74(22):1785-9. PubMed ID: 20513814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Compensating for central nervous system dysmyelination: females with a proteolipid protein gene duplication and sustained clinical improvement.
    Inoue K; Tanaka H; Scaglia F; Araki A; Shaffer LG; Lupski JR
    Ann Neurol; 2001 Dec; 50(6):747-54. PubMed ID: 11761472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.
    Nevin ZS; Factor DC; Karl RT; Douvaras P; Laukka J; Windrem MS; Goldman SA; Fossati V; Hobson GM; Tesar PJ
    Am J Hum Genet; 2017 Apr; 100(4):617-634. PubMed ID: 28366443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The microglial reaction in spinal cords of jimpy mice is related to apoptotic oligodendrocytes.
    Vela JM; Dalmau I; González B; Castellano B
    Brain Res; 1996 Mar; 712(1):134-42. PubMed ID: 8705296
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Sase S; Almad AA; Boecker CA; Guedes-Dias P; Li JJ; Takanohashi A; Patel A; McCaffrey T; Patel H; Sirdeshpande D; Curiel J; Shih-Hwa Liu J; Padiath Q; Holzbaur EL; Scherer SS; Vanderver A
    Elife; 2020 May; 9():. PubMed ID: 32463361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel mutations in the GJC2 gene associated with Pelizaeus-Merzbacher-like disease.
    Owczarek-Lipska M; Mulahasanovic L; Obermaier CD; Hörtnagel K; Neubauer BA; Korenke GC; Biskup S; Neidhardt J
    Mol Biol Rep; 2019 Aug; 46(4):4507-4516. PubMed ID: 31270756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oligodendrocyte development and differentiation in the rumpshaker mutation.
    Fanarraga ML; Sommer IU; Griffiths IR; Montague P; Groome NP; Nave KA; Schneider A; Brophy PJ; Kennedy PG
    Glia; 1993 Oct; 9(2):146-56. PubMed ID: 7503954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathologic and phenotypic alterations in a mouse expressing a connexin47 missense mutation that causes Pelizaeus-Merzbacher-like disease in humans.
    Tress O; Maglione M; Zlomuzica A; May D; Dicke N; Degen J; Dere E; Kettenmann H; Hartmann D; Willecke K
    PLoS Genet; 2011 Jul; 7(7):e1002146. PubMed ID: 21750683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hereditary leukodystrophies without identified mutations.
    Robitaille Y
    J Neurol Sci; 2005 Feb; 228(2):208-9. PubMed ID: 15694209
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro death of jimpy oligodendrocytes: correlation with onset of DM-20/PLP expression and resistance to oligodendrogliotrophic factors.
    Williams WC; Gard AL
    J Neurosci Res; 1997 Oct; 50(2):177-89. PubMed ID: 9373028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glial conditioned medium enables jimpy oligodendrocytes to express properties of normal oligodendrocytes: production of myelin antigens and membranes.
    Bartlett WP; Knapp PE; Skoff RP
    Glia; 1988; 1(4):253-9. PubMed ID: 2467882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A severe connatal form of Pelizaeus Merzbacher disease in a Czech boy caused by a novel mutation (725C>A, Ala242Glu) at the 'jimpy(msd) codon' in the PLP gene.
    Seeman P; Paderova K; Benes V; Sistermans EA
    Int J Mol Med; 2002 Feb; 9(2):125-9. PubMed ID: 11786921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Understanding glial abnormalities associated with myelin deficiency in the jimpy mutant mouse.
    Vela JM; González B; Castellano B
    Brain Res Brain Res Rev; 1998 Mar; 26(1):29-42. PubMed ID: 9600623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.